GreenWood Investors recently released its Q2 2020 Investor Letter, a copy of which you can download here. Steven Wood, CFA founded Greenwood Investors, LLC in 2010. This year so far the fund has underperformed its benchmark the MSCI ACWI All Cap. You should check out GreenWood's top 5 stock picks for investors to buy right […]...
Since the equity markets hit a bottom in March, the bull run has been the strongest since the Great Depression, according to the Wall Street Journal. But sustaining this will not be easy. If anything, it's probably a good idea to consider safe stocks to buy for your portfolio.One of the risks for the markets is the upcoming election. With the novel coronavirus, there will be a much larger portion of the population that will vote by mail -- and this could easily delay the results. The uncertainty could mean a spike in volatility. In fact, this happened during the election in 2000.Next, there are signs of frothiness. Many tech stocks and IPOs have seen parabolic moves on the upside. Perhaps the most notable example of the exuberance is when Tesla (NASDAQ:TSLA) stock jumped because of an announcement of a stock split. Keep in mind that this kind of market action...
What's next for Novavax (NASDAQ:NVAX) stock? The novel coronavirus vaccine maker has scored several major supply deals. But, with shares up nearly 3600% so far in 2020, can we expect another parabolic move higher?Source: Ascannio/Shutterstock.com Yes and no. On one hand, the Covid-19 vaccine horse race isn't a winner-take-all situation. It's not as if a rival candidate will take 100% of the worldwide market. As seen from the UK and South Korea deals, this company stands to gain massive business - if and when it's candidate obtains regulatory approval.But, that's where the problem may be. Unlike some of its rivals, Novavax is behind in bringing its candidate, NVX-CoV2373, to market. For example, Moderna's (NASDAQ:MRNA) candidate could announce Phase 3 clinical trial results as soon as October.InvestorPlace - Stock Market News, Stock Advice & Trading TipsYet, that month is when Novavax's candidate plans to start Phase 3 trials. Simply put, it's the...
Aug.21 -- The appetite for electric vehicles continues to be strong and Tesla Inc. is the "king of the hill," Dan Ives, Wedbush Securities managing director, says during an interview with Bloomberg's Alix Steel on "Bloomberg Markets." Ives, his family and his firm do not own shares of Tesla....
